Multidrug resistance in breast cancer: Mechanisms, strategies
- 30 November 1995
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31, S15-S17
- https://doi.org/10.1016/0959-8049(95)00293-r
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Multidrug ResistancePublished by Springer Science and Business Media LLC ,2011
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Characterization of a Topoisomerase II Gene Rearrangement in a Human Small-Cell Lung Cancer Cell LineJNCI Journal of the National Cancer Institute, 1992
- Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristineEuropean Journal of Cancer and Clinical Oncology, 1991
- Multidrug resistance from the clinical point of viewEuropean Journal of Cancer and Clinical Oncology, 1991
- Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase InhibitorsJNCI Journal of the National Cancer Institute, 1989